| Pangenomic classification of pituitary neuroendocrine tumors M Neou, C Villa, R Armignacco, A Jouinot, ML Raffin-Sanson, A Septier, ... Cancer cell 37 (1), 123-134. e5, 2020 | 221 | 2020 |
| Metformin as a new anti-cancer drug in adrenocortical carcinoma G Poli, G Cantini, R Armignacco, R Fucci, R Santi, L Canu, G Nesi, ... Oncotarget 7 (31), 49636, 2016 | 46 | 2016 |
| KDM1A inactivation causes hereditary food-dependent Cushing syndrome A Vaczlavik, L Bouys, F Violon, G Giannone, A Jouinot, R Armignacco, ... Genetics in Medicine 24 (2), 374-383, 2022 | 37 | 2022 |
| 2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma G Poli, E Ceni, R Armignacco, T Ercolino, L Canu, G Baroni, G Nesi, ... Oncotarget 6 (8), 5695, 2015 | 36 | 2015 |
| New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer F Salvianti, L Canu, G Poli, R Armignacco, C Scatena, G Cantini, ... Oncotarget 8 (39), 65525, 2017 | 35 | 2017 |
| Fascin-1 is a novel prognostic biomarker associated with tumor invasiveness in adrenocortical carcinoma G Poli, C Ruggiero, G Cantini, L Canu, G Baroni, R Armignacco, A Jouinot, ... The Journal of Clinical Endocrinology & Metabolism 104 (5), 1712-1724, 2019 | 34 | 2019 |
| Human fetal adrenal cells retain age‐related stem‐and endocrine‐differentiation potential in culture G Poli, E Sarchielli, D Guasti, S Benvenuti, L Ballerini, B Mazzanti, ... The FASEB Journal 33 (2), 2263-2277, 2019 | 34 | 2019 |
| Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis R Armignacco, G Cantini, L Canu, G Poli, T Ercolino, M Mannelli, ... Journal of Endocrinological Investigation 41 (5), 499-507, 2018 | 20 | 2018 |
| The adipose stem cell as a novel metabolic actor in adrenocortical carcinoma progression: evidence from an in vitro tumor microenvironment crosstalk model R Armignacco, G Cantini, G Poli, D Guasti, G Nesi, P Romagnoli, ... Cancers 11 (12), 1931, 2019 | 19 | 2019 |
| Genomics of benign adrenocortical tumors A Jouinot, R Armignacco, G Assié The Journal of Steroid Biochemistry and Molecular Biology 193, 105414, 2019 | 15 | 2019 |
| Prognostic and monitoring value of circulating tumor cells in adrenocortical carcinoma: A preliminary monocentric study G Cantini, L Canu, R Armignacco, F Salvianti, G De Filpo, T Ercolino, ... Cancers 12 (11), 3176, 2020 | 13 | 2020 |
| Identification of glucocorticoid-related molecular signature by whole blood methylome analysis R Armignacco, A Jouinot, L Bouys, A Septier, T Lartigue, M Neou, ... European Journal of Endocrinology 186 (2), 297-308, 2022 | 8 | 2022 |
| Whole blood methylome-derived features to discriminate endocrine hypertension R Armignacco, PS Reel, S Reel, A Jouinot, A Septier, C Gaspar, ... Clinical Epigenetics 14 (1), 142, 2022 | 4 | 2022 |
| Transcriptome in paraffin samples for the diagnosis and prognosis of adrenocortical carcinoma A Jouinot, J Lippert, M Sibony, F Violon, L Jeanpierre, D De Murat, ... European Journal of Endocrinology 186 (6), 607-617, 2022 | 4 | 2022 |
| Caractérisation du microenvironnement des cancers de la surrénale par transcriptome single-cell A Jouinot, Y Martin, T Foulonneau, Y Bendjelal, P Calvet, F Violon, ... Annales d'Endocrinologie 84 (5), 520, 2023 | | 2023 |
| Signature transcriptomique du syndrome de Cushing dans le sang total MF Birtolo, R Armignacco, N Benanteur, D De Murat, L Guignat, ... Annales d'Endocrinologie 84 (5), 552, 2023 | | 2023 |
| Whole blood transcriptomic signature of Cushing MF Birtolo, R Armignacco, N Benanteur, MD De, L Guignat, L Groussin, ... Endocrine Abstracts 93, 2023 | | 2023 |
| Tumor microenvironment of adrenocortical carcinoma dissected by single-cell RNA-sequencing A Jouinot, Y Martin, T Foulonneau, Y Bendjelal, P Calvet, F Violon, ... Endocrine Abstracts 90, 2023 | | 2023 |
| OR04-3 Genetic Alterations of ARMC5 and KDM1A Are Associated With Different Expression Profiles of Illegitimate Receptors in Primary Bilateral Macronodular Adrenal Hyperplasia R Armignacco, G Assié, M Barat, J Bertherat, A Berthon, ... Journal of the Endocrine Society 6 (Supplement_1), A80-A81, 2022 | | 2022 |
| Les mutations d’ARMC5 et KDM1A sont associées à des profils différentiels d’expression de récepteurs illégitimes dans l’hyperplasie macronodulaire bilatérale des surrénales L Bouys, V Florian, A Vaczlavik, G Giannone, A Jouinot, R Armignacco, ... Annales d'Endocrinologie 83 (5), 321-322, 2022 | | 2022 |
